Literature DB >> 17687536

[Meta-analyses. A tool for maximizing therapy study evidence?].

W Maier1, H-J Möller.   

Abstract

Medical decisions have to rely on evidence-based medicine. However, evidence is not a clearly defined term. Several evidence criteria have been proposed, yet statistical meta-analyses are considered to be core criterion of empirical studies in that they combine single evidence from different studies into an encompassing conclusion. We argue however that meta-analyses have major limitations in this context. Five arguments are presented: (1) the nature of a study design affects the results and thus comprehensive meta-analyses covering studies with different designs are not informative; (2) combining different studies into a meta-analysis is methodologically not informative; (3) meta-analyses consider the variance between studies not as informative but as random noise; (4) the strategy to identify informative studies is a decisive determinant of meta-analyses; and (5) the value of conclusions from meta-analyses depends on the choice of statistics chosen as combined results from the various single studies. Instead, meta-analyses are useful tools for generating hypotheses in a posteriori analysis.

Mesh:

Year:  2007        PMID: 17687536     DOI: 10.1007/s00115-007-2308-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  17 in total

1.  Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

Authors:  I M Anderson
Journal:  J Affect Disord       Date:  2000-04       Impact factor: 4.839

2.  [Evidence of evidence-based medicine?].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2002-01       Impact factor: 1.214

3.  A meta-analysis of the efficacy of second-generation antipsychotics.

Authors:  John M Davis; Nancy Chen; Ira D Glick
Journal:  Arch Gen Psychiatry       Date:  2003-06

Review 4.  Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.

Authors:  Hans Melander; Jane Ahlqvist-Rastad; Gertie Meijer; Björn Beermann
Journal:  BMJ       Date:  2003-05-31

5.  New generation versus conventional antipsychotics.

Authors:  John Geddes; Paul Harrison; Nick Freemantle
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

Review 6.  Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.

Authors:  Dean Fergusson; Steve Doucette; Kathleen Cranley Glass; Stan Shapiro; David Healy; Paul Hebert; Brian Hutton
Journal:  BMJ       Date:  2005-02-19

Review 7.  Efficacy of antidepressants in adults.

Authors:  Joanna Moncrieff; Irving Kirsch
Journal:  BMJ       Date:  2005-07-16

Review 8.  [Problems of evidence-based medicine in psychopharmacotherapy: problems of evidence grading and of the evidence basis for complex clinical decision making].

Authors:  H-J Möller; W Maier
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

9.  Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.

Authors:  David Gunnell; Julia Saperia; Deborah Ashby
Journal:  BMJ       Date:  2005-02-19

Review 10.  Meta-analysis: statistical alchemy for the 21st century.

Authors:  A R Feinstein
Journal:  J Clin Epidemiol       Date:  1995-01       Impact factor: 6.437

View more
  3 in total

1.  Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008.

Authors:  Hans Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11-19       Impact factor: 5.270

Review 2.  Is evidence sufficient for evidence-based medicine?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

Review 3.  Do effectiveness ("real world") studies on antipsychotics tell us the real truth?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-07-11       Impact factor: 5.270

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.